Skip to main content

Advertisement

SpringerLink
Log in

Assessment of the efficacy of early phase parameters by 123I-MIBG dynamic imaging for distinguishing Lewy body-related diseases from Parkinson’s syndrome

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

The aim of this study was to assess the efficacy of early phase washout rate (early WR) and area under the time–activity curve (AUTAC) by 123I-metaiodobenzylguanidine (MIBG) dynamic chest imaging for distinguishing Lewy body-related diseases (LBRD) from Parkinson’s syndrome (PS) and reducing examination time.

Methods

Sixty-two patients with suspected LBRD who underwent 123I-MIBG dynamic imaging in early phase were retrospectively selected. The early WR and AUTAC were calculated from 123I-MIBG dynamic data of the heart. We evaluated the relationships between proposed and conventional parameters by using Spearman’s rank correlation coefficient. Differences in parameters between LBRD and PS groups were tested for statistical significance using the Mann–Whitney U test. The diagnostic performance of all parameters for distinguishing LBRD from PS was assessed in terms of receiver operating characteristic (ROC) analysis. Additionally, combination diagnostic performance and concordance rate between early phase parameters and late H/M ratio by kappa statistics were also assessed.

Results

The early WR and AUTAC showed a positive and negative correlation with conventional parameters. Both the early WR and AUTAC of LBRD group were significantly distinguishable from those of the PS group (p < 0.001). Area under the ROC curve of the early WR (0.98) was greater than that of AUTAC (0.91). The diagnostic performance of combination of the early phase parameters was 93 % sensitivity and 100 % specificity. Moreover, the early phase parameters showed excellent agreement with late H/M ratio (k = 0.93).

Conclusions

The early WR and AUTAC showed high performance for distinguishing LBRD from PS, and the combination diagnosis with early H/M ratio and early WR contribute to improve the diagnostic performance. Thus, these parameters would be useful for reducing the examination time of myocardial 123I-MIBG scintigraphy to diagnose LBRD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yamashina S, Yamazaki J. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging. 2007;34:939–50.

    Article  PubMed  Google Scholar 

  2. Uchiyama Y, Momose M, Kondo C, Kusakabe K, Uchiyama S. Comparison of parameters of 123I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features. Ann Nucl Med. 2011;25:478–85.

    Article  PubMed  Google Scholar 

  3. Treglia G, Cason E, Stefanelli A, et al. MIBG scintigraphy in differential of Parkinsonism: a meta-analysis. Clin Auton Res. 2012;22:43–55.

    Article  PubMed  Google Scholar 

  4. Orimo S, Suzuki M, Inaba A, Mizusawa H. 123I-MIBG myocardial scintigraphy for differentiating Parkinson’s disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2012;18:494–500.

    Article  PubMed  Google Scholar 

  5. Taki J, Yoshita M, Yamada M, Tonami N. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med. 2004;18:453–61.

    Article  PubMed  Google Scholar 

  6. Suzuki M, Kurita A, Hashimoto M, Fukumitsu N, Abo M, Ito Y, et al. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson’s disease. J Neurol Sci. 2006;240:15–9.

    Article  CAS  PubMed  Google Scholar 

  7. Orimo S. Clinical and pathological study on early diagnosis of Parkinson’s disease and dementia with Lewy bodies. Rinsho Shinkeigaku. 2008;48:11–24.

    Article  PubMed  Google Scholar 

  8. Fujishiro H, Nakamura S, Kitazawa M, Sato K, Iseki E. Early detection of dementia with Lewy bodies in patients with amnestic mild cognitive impairment using 123I-MIBG cardiac scintigraphy. J Neurol Sci. 2012;315:115–9.

    Article  PubMed  Google Scholar 

  9. Kashihara K, Imamura T, Shinya T. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson’s disease. Parkinsonism Relat Disord. 2010;16:252–5.

    Article  PubMed  Google Scholar 

  10. Miyamoto T, Miyamoto M, Suzuki K, Ikematsu A, Usui Y, Inoue Y, et al. Comparison of severity of obstructive sleep apnea and degree of accumulation cardiac 123I-MIBG radioactivity as a diagnostic marker for idiopathic REM sleep behavior disorder. Sleep Med. 2009;10:577–80.

    Article  PubMed  Google Scholar 

  11. King AE, Mintz J, Royall DR. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord. 2011;26:1218–24.

    Article  PubMed  Google Scholar 

  12. Agostini D, Carrio I, Verberne HJ. How to use myocardial 123I-MIBG scintigraphy in chronic heart failure. Eur J Nucl Med Mol Imaging. 2009;36:555–9.

    Article  PubMed  Google Scholar 

  13. Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schäfers M, et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802–12.

    Article  PubMed  Google Scholar 

  14. Muxí A, Paredes P, Navales I, Valldeoriola F, Gaig C, Lomeña F, et al. Diagnostic cutoff points for 123I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson’s disease. Eur J Nucl Med Mol Imaging. 2011;38:1139–46.

    Article  PubMed  Google Scholar 

  15. Arbab AS, Koizumi K, Takano H, Uchiyama G, Arai T, Mera K. Parameters of dynamic and static iodine-123-MIBG cardiac imaging. J Nucl Med. 1995;36:962–8.

    CAS  PubMed  Google Scholar 

  16. Arimoto T, Takeishi Y, Fukui A, Tachibana H, Nozaki N, Hirono O, et al. Dynamic 123I-MIBG SPECT reflects sympathetic nervous integrity and predicts clinical outcome in patients with chronic heart failure. Ann Nucl Med. 2004;18:145–50.

    Article  PubMed  Google Scholar 

  17. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson’s disease. Ann Neurol. 1992;32:125–7.

    Article  Google Scholar 

  18. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113–24.

    Article  CAS  PubMed  Google Scholar 

  20. International Classification of Sleep Disorders. Diagnostic and coding manual. 2nd ed. Westchester: American Academy of Sleep Medicine; 2005.

    Google Scholar 

  21. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Veltman CE, Boogers MJ, Meinardi JE, AI Younis I, Dibbets-Schneider P, Van der Wall EE, et al. Reproducibility of planar 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging. 2012;39:1599–608.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–5.

    Article  CAS  PubMed  Google Scholar 

  24. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17:427–42.

    Article  CAS  PubMed  Google Scholar 

  25. Okuda K, Nakajima K, Hosoya T, Ishikawa T, Konishi T, Matsubara K, et al. Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging. J Nucl Cardiol. 2011;18:82–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are thanks to Yasuyoshi Kuroiwa, Ph.D. and Junichi Saito, R.T. and other members of Department of Radiological Technology, Koga general Hospital, for their assistance.

Author information

Authors and Affiliations

  1. Department of Radiological Technology, Koga General Hospital, 1749-1 Sudaki, Ikeuchi-Cho, Miyazaki, 880-0041, Japan

    Takuro Shiiba & Masaji Maeda

  2. Department of Health Sciences, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan

    Takuro Shiiba

  3. Department of Radiology, University of Miyazaki, 5200 Kihara, Kiyotake-Cho, Miyazaki, 889-1692, Japan

    Ryuichi Nishii

  4. Department of Health Sciences, Faculty of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan

    Masayuki Sasaki & Junji Morishita

  5. Department of Radiology, Koga General Hospital, 1749-1 Sudaki, Ikeuchi-Cho, Miyazaki, 880-0041, Japan

    Yasushi Kihara

  6. Department of Neurology, Junwakai Memorial Hospital, 1119 Komatsu, Miyazaki, 880-2112, Japan

    Kazuhito Tsuruta

Authors
  1. Takuro Shiiba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryuichi Nishii
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masayuki Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasushi Kihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazuhito Tsuruta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masaji Maeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Junji Morishita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takuro Shiiba.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shiiba, T., Nishii, R., Sasaki, M. et al. Assessment of the efficacy of early phase parameters by 123I-MIBG dynamic imaging for distinguishing Lewy body-related diseases from Parkinson’s syndrome. Ann Nucl Med 29, 149–156 (2015). https://doi.org/10.1007/s12149-014-0923-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-014-0923-9

Keywords

Search

Navigation